Efficacy of rifaximin in the treatment of chronic relapsing diverticulitis
Aim of investigation. To estimate efficacy of rifaximin in complex conservative treatment of chronic diverticulitis.Material and methods. The main group included 43 patients that received 200 mg rifaximin every 8 h within conservative treatment mode for 14 days. Of all patients 34 were women (79,1%)...
Saved in:
Main Authors: | S. I. Achkasov, A. I. Moskalyov, Yu. L. Trubachyova, A. F. Filon |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Gastro LLC
2012-04-01
|
Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
Subjects: | |
Online Access: | https://www.gastro-j.ru/jour/article/view/1282 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comprehensive Ultrasound Diagnosis of Sigmoid Diverticulitis
by: A. I. Кoushnerou, et al.
Published: (2021-12-01) -
Russian Non-Interventional Study of the Efficacy and Tolerability of Rifaximin-α Therapy in Patients with Uncomplicated Diverticular Disease under the Conditions of Outpatient Practice
by: O. S. Shifrin, et al.
Published: (2020-04-01) -
Effect of Rifaximin and a Multi-Strain Probiotic on the Intestinal Microbiome and Cardiovascular Risk Indicators in Patients with Coronary Heart Disease
by: E. A. Kashukh, et al.
Published: (2019-09-01) -
Pregnancy and Healthy Childbirth in a 37 Year-Old Patient with Diverticular Disease
by: P. S. Andreev, et al.
Published: (2020-12-01) -
Practical Recommendation of the Scientific Сommunity for Human Microbiome Research (CHMR) and the Russian Gastroenterological Association (RGA) on Small Intestinal Bacterial Overgrowth in Adults
by: V. T. Ivashkin, et al.
Published: (2022-09-01)